Selected Grants
2/3 CTSA K12 Program at Duke University
ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030Targeting Undruggable Transcription Factor HoxB13 to Inhibit Prostate Cancer Metastasis
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2025 - 2029Understanding and targeting epigentic regulation of immune evasion in prostate cancer
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2029Testing ATAD2 as a new therapeutic target for advanced prostate cancer
ResearchPrincipal Investigator · Awarded by University of California - Los Angeles · 2024 - 2029Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029NEUROD1 function in SCLC fate and plasticity
ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2029Assessment of the Optimal Settings of TFL for Laser Lithotripsy and Associated Thermal Injury Risk
ResearchCo Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2025 - 2028The Duke Preparing Research scholars In bioMEdical sciences (PRIME): Cancer Research Program
ResearchPreceptor · Awarded by National Cancer Institute · 2023 - 2028Targeting MED31-driven transcription recycling in lethal prostate cancer
ResearchCo Investigator · Awarded by National Cancer Institute · 2023 - 2028The role of focal adhesion kinase in therapy resistant prostate tumors
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2028NUAK2 as a novel splicing regulatory kinase in Neuroendocrine Prostate Cancer
ResearchCo-Mentor · Awarded by Department of Defense · 2025 - 2027Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer
ResearchCo Investigator · Awarded by National Cancer Institute · 2022 - 2027Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
ResearchCo Investigator · Awarded by National Cancer Institute · 2022 - 2027Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology for Prostate Cancer
ResearchCo Investigator · Awarded by National Cancer Institute · 2022 - 2027Interrupting the aberrant cancer development sequence in epithelial cancer progression
ResearchMentor · Awarded by Prostate Cancer Foundation · 2021 - 2027ASXL2/MLL3/MLL4 complexes in prostate cancer therapy
ResearchCo Investigator · Awarded by Mike Slive Foundation · 2026 - 2026Glutaminase I isoforms as personalized biomarkers of prostate cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2026Targeting neuroendocrine cells in prostate cancer with small molecule and targeted radionuclide therapies
ResearchCo-Principal Investigator · Awarded by Prostate Cancer Foundation · 2023 - 2026Targeting NUAK2 in neuroendocrine prostate cancer
ResearchCo Investigator · Awarded by Department of Defense · 2023 - 2026Defining Cellular and Genetic Factors for Renal Cell Carcinoma Subtypes
ResearchCollaborator · Awarded by Department of Defense · 2022 - 2026Murine modeling and immunotherapeutic targeting of GPC3 positive prostate cancer
ResearchCollaborating Investigator · Awarded by Mike Slive Foundation · 2025 - 2026Cell and Molecular Biology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 2021 - 2026Blocking glutamine utilization in advanced and therapy-resistant prostate cancer
ResearchCo-Mentor · Awarded by Department of Defense · 2024 - 2026Delineate the role of GSTP1 in Aggressive Prostate Cancer
ResearchPrincipal Investigator · Awarded by University of California - Los Angeles · 2023 - 2026Exploitation of a new targetable node in the AR signaling pathway in prostate cancer
ResearchCollaborator · Awarded by Department of Defense · 2022 - 2025Targeting oncogenomic function of N-Myc to inhibit neuroendocrine prostate cancer visceral metastasis
ResearchCo Investigator · Awarded by Department of Defense · 2023 - 2025Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
ResearchCollaborator · Awarded by National Institutes of Health · 2019 - 2025Role of JMJD1A modifications in castration resistance of prostate cancer
ResearchCo Investigator · Awarded by University of Maryland, Baltimore · 2022 - 2025PRMT5/MEP50 as a critical epigenetic regulator and therapeutic target for therapy-induced neuroendocrine prostate cancer
ResearchPrincipal Investigator · Awarded by Purdue University · 2022 - 2025Preclinical studies of DRP-104 in targeting glutamine metabolism of prostate cancer
ResearchPrincipal Investigator · Awarded by Dracen Pharmaceuticals · 2022 - 2025Targeting NUAK2 to mitigate obesity-enhanced prostate cancer growth and metastasis
ResearchCo Investigator · Awarded by Department of Defense · 2021 - 2024Transcriptional reprogramming of lethal small cell prostate cancer
ResearchCollaborator · Awarded by Department of Defense · 2021 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024A novel mitotic regulatory axis in neuroendocrine prostate cancer
ResearchPrincipal Investigator · Awarded by University of Pittsburgh · 2019 - 2024Targeting neuroendocrine prostate cancer by engineering 3' untranslated regions
ResearchCo Investigator · Awarded by Department of Defense · 2020 - 2024Confirmation of histologic SCNC (NEPC)
ResearchPrincipal Investigator · Awarded by BioXcel Therapeutics · 2019 - 2024Targeting glutamine utilization in therapy-resistant prostate cancer
ResearchMentor · Awarded by Department of Defense · 2021 - 2024Heat Shock Factor 1 drives prostate cancer progression through production of antioxidants and cellular energy
ResearchMentor · Awarded by Department of Defense · 2021 - 2023Targeting RNA splicing in race-related aggressive and lethal prostate cancer
Clinical TrialCo Investigator · Awarded by Prostate Cancer Foundation · 2018 - 2023Role and targeting of PRMT5 in prostate cancer
ResearchPrincipal Investigator · Awarded by Purdue University · 2017 - 2023Targeting Glutaminase Isoforms for Therapy-Resistant Prostate Cancer
ResearchPrincipal Investigator · Awarded by Department of Defense · 2019 - 2022Defining the Essential Determinants of Prostate Cancer Differentiation States
ResearchMentor · Awarded by National Institutes of Health · 2019 - 2022Targeting the p38/Snail/PD-L1 axis in hormone-therapy resistance and metastasis
ResearchCo Investigator · Awarded by Department of Defense · 2018 - 2022Role of oncogenic phosphorylated MED1 in aggressive prostate cancer
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2017 - 2022Targeting castration-resistant prostate cancer by engineering 3'UTR
ResearchCollaborator · Awarded by Department of Defense · 2020 - 2022Unveiling the roles of neuroendocrine cells in prostate cancer development
ResearchPrincipal Investigator · Awarded by Mike Slive Foundation · 2020 - 2021Novel Tumor Suppressive Role of Phosphodiesterases in Prostate Cancer
ResearchPrincipal Investigator · Awarded by Department of Defense · 2016 - 2021Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2021Assessment of macrophage density in historical tNEPC tissue samples.
ResearchPrincipal Investigator · Awarded by BioXcel Therapeutics · 2019 - 2021Identification of DNA methylation markers for risk of metastasis in localized prostate cancer
ResearchPrincipal Investigator · Awarded by Kaiser Permanente · 2016 - 2020Heparan sulfate in prostate cancer
ResearchPrincipal Investigator · Awarded by University of South Florida · 2019 - 2020Targeting Adaptive Pathways in Abiraterone- and Enzalutamide-Refractory Intermediate Atypical Carcinoma
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2016 - 2019Role of the Stroma in Fibrolamellar Hepatocellular Carcinoma
ResearchCollaborator · Awarded by Fibrolamellar Cancer Foundation · 2016 - 2019Genetic screen of calorie restricted and western diet essential kinases in prostate cancer
ResearchMentor · Awarded by Prostate Cancer Foundation · 2018 - 2019Heparan sulfate in prostate cancer
ResearchPrincipal Investigator · Awarded by University of Georgia · 2018 - 2018Paired Acquisition In Refractory Prostate Cancer (PAIR): Advancing the Promise of the PCF/SU2C/AACR West Coast Prostate Cancer Dream Team
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2016 - 2018A novel strategy to identify prostate cancer biomarkers for patient management
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2018Systems Analysis of Epigenomic Architecture in Cancer Progression
ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2017 - 2018: Identification of DNA methylation markers for risk of metastasis in localized prostate cancer
ResearchPrincipal Investigator · Awarded by Kaiser Permanente · 2016 - 2016Stand Up 2 Cancer West Coast Dream Team Grant
ResearchPrincipal Investigator · Awarded by University of San Francisco · 2013 - 2016External Relationships
- Artera
- Chimigen Bio
- Kingmed Diagnostics
- MoreHealth
- OptraScan
- SISU Pharma
- York Biotechnology
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.